Syngene International Limited (BOM:539268)
592.15
-8.70 (-1.45%)
At close: Jan 22, 2026
Syngene International Revenue
Syngene International had revenue of 9.17B INR in the quarter ending December 31, 2025, a decrease of -2.82%. This brings the company's revenue in the last twelve months to 37.20B, up 5.05% year-over-year. In the fiscal year ending March 31, 2025, Syngene International had annual revenue of 36.42B with 4.41% growth.
Revenue (ttm)
37.20B
Revenue Growth
+5.05%
P/S Ratio
6.34
Revenue / Employee
5.69M
Employees
6,533
Market Cap
235.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 36.42B | 1.54B | 4.41% |
| Mar 31, 2024 | 34.89B | 2.96B | 9.26% |
| Mar 31, 2023 | 31.93B | 5.89B | 22.61% |
| Mar 31, 2022 | 26.04B | 4.20B | 19.22% |
| Mar 31, 2021 | 21.84B | 1.72B | 8.57% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mangalore Refinery and Petrochemicals | 895.19B |
| NBCC (India) | 129.42B |
| Force Motors | 86.24B |
| Deepak Nitrite | 78.75B |
| Asahi India Glass | 46.84B |
| Himadri Speciality Chemical | 45.08B |
| Emami | 37.15B |
| Manappuram Finance | 35.18B |
Syngene International News
- 5 weeks ago - Syngene International Ltd Webinar on Clinical Trials Market Call Transcript - GuruFocus
- 2 months ago - Syngene International Ltd (BOM:539268) Q2 2026 Earnings Call Highlights: Navigating Growth ... - GuruFocus
- 2 months ago - Q2 2026 Syngene International Ltd Earnings Call Transcript - GuruFocus
- 6 months ago - Goldman Sachs maintains buy on Syngene, bullish on FY26 early-teens growth outlook, sees 15.5% upside on Q1 beat and rising CRO-led margin gains - Business Upturn
- 6 months ago - Syngene Q1 profit up 59% to Rs 87 crore - The Times of India
- 6 months ago - Syngene International Q1 Results: Revenue grows 11% YoY to Rs 790 crore, Net profit jumps 59% YoY - Business Upturn
- 8 months ago - Syngene International receives EIR from USFDA for Biocon Park facility, inspection concludes with VAI classification - Business Upturn
- 9 months ago - Why are Syngene shares down 10% despite Q4 net profit jumping 2.8% YoY? - Business Upturn